IMMUDEX ApS
Nøgletal
- Afkastningsgrad
- -22,4 %
- Egenkapitalforrentning
- -68,7 %
- Likviditetsgrad
- 115,5 %
- Soliditetsgrad
- 32,7 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | 22.665.406 |
Driftsresultat | -10.987.916 |
Finansielle indtægter | 33.449 |
Finansielle omkostninger | 2.569.542 |
Skat af årets resultat | -2.110.414 |
Årets resultat | -11.025.449 |
Medarbejdere
| Regnskabsperiode | |
|---|---|
Gns. ansatte | 40 |
Personaleomkostninger | 31.671.418 kr. |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 5.293.676 |
Kortfristede aktiver | 33.773.678 |
Langfristede aktiver | 15.322.433 |
Aktiver i alt | 49.096.111 |
Egenkapital | 16.050.190 |
Forpligtelser i alt | 33.045.921 |
Kortfristede forpligtelser | 29.235.002 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Varebeholdninger | 9.612.643 |
Tilgodehavender fra salg og tjenesteydelser | 2.610.047 |
Andre kortfristede tilgodehavender | 1.444.410 |
Leverandørgæld | 3.735.200 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 740.349 |
Overført resultat | 8.329.024 |
Investeringer og aktiver
| Regnskabsperiode | |
|---|---|
Langfristede investeringer og tilgodehavender | 531.819 |
Materielle anlægsaktiver | 3.077.841 |
Højdepunkter fra årsrapporten
Forretning og udvikling
Description of key activities of the companyThe main activities of Immudex are to provide MHC Dextramer® reagents and services for improved cellular immune monitoring to be used in research, clinical development and patient monitoring.
The Company has during the fiscal year had the following focus areas:…
Risici og væsentlige forhold
Uncertainties related to recognition and measurementThe value of the capitalized development projects depends on the companys ability to finalize the development projects in progress and the companys ablility to attract enough customers to achieve a return of the invested capital. The assessment of the management is that this will happen within a manageable timeline.
1.
Uncertainties concerning recognition and measurementThe value of the capitalized development projects depends on the companys ability to finalize the development projects in progress and the companys ablility to attract enough customers to achieve a return of the invested capital. The assessment of the management is that this will happen within a manageable timeline.
Events occurring after the end of the financial yearNo events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.
Forpligtelser og sikkerhedsstillelser
17.Contractual obligations and contingencies, etc.
DKK in thousands…
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger